Abstract
A 47-year-old woman demonstrated bilateral wrist joint pain during 4 weeks. Her status did not fulfill the ACR classification criteria for RA, and her symptoms had almost disappeared 4 weeks later. After about 1 year, she again complained of tenderness and swelling in the bilateral wrist joints. The laboratory data were as follows: ESR:61 mm/hour, CRP: 1.0 mg/dl, RF: 172 IU/ml, MMP-3: 178.7 ng/ml, and anti-cyclic citrullinated peptide antibodies (aCCP): 488 U/ml. Based on these findings, we diagnosed the patient as having RA. She was treated with several anti-rheumatic drugs, and joint symptoms decreased. This case was regarded as undifferentiated arthritis at the first visit. We later found the high titers of aCCP using her frozen sera after she fulfilled with ACR critera for RA, although aCCP was not checked at first time because its analysis was not covered by national health insurance in Japan. Thus, it is possible that this patient should have been treated as having RA from the first visit. In general, aCCP shows excellent specificity for RA diagnosis although sensitivity is lower. In contrast, it has demonstrated that aCCP is positive in about 40% of patients 1 year before the onset of RA. The clinical outcomes of patients with joint symptoms and positive aCCP analysis, but do not fulfill the ACR criteria for RA, should be assessed in plural patients.
Highlights
The early diagnosis of rheumatoid arthritis (RA) is important in order to prevent crippling
It has been reported that anti-cyclic citrullinated peptide antibody (aCCP) had a positive predictive value (PPV) of approximately 90% for RA aCCP was positive in 50%–70% of patients with early RA.[4]
Present case at the first visit was regarded as primary sjögren syndrome (SS). aCCP was not checked at that time because its analysis was not covered by national health insurance in Japan
Summary
The early diagnosis of rheumatoid arthritis (RA) is important in order to prevent crippling. Anti-cyclic citrullinated peptide antibodies (aCCP) were proposed as a useful diagnostic and predictive marker in RA.[1,2,3] It has been reported that aCCP had a positive predictive value (PPV) of approximately 90% for RA aCCP was positive in 50%–70% of patients with early RA.[4] In this regard, Symmons et al have emphasized that there is no set of predictive criteria that has been able to discriminate between indivisuals destined to develop RA and those not developing RA.[5] This letter describes the time-course of serum aCCP levels in a patient with sjögren syndrome (SS) accompanied by RA during the observation of SS, and a literature review of the clinical significance of positive aCCP preceding the fulfillment with ACR criteria for RA. A 47-year-old woman demonstrated bilateral wrist joint pain.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical medicine. Arthritis and musculoskeletal disorders
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
